TargetMol

BE 2254

Product Code:
 
TAR-T26759
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26759-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26759-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26759-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
BE 2254 is an antagonist of central noradrenergic receptor.
CAS:
40077-13-2
Formula:
C19H21NO2
Molecular Weight:
295.382
Purity:
0.98
SMILES:
Oc1ccc(CCNCC2CCc3ccccc3C2=O)cc1

References

1. Szreder Z. The effect of BE 2254 on the metabolic response stimulated by pyrogen in rabbits. Gen Pharmacol. 1993 Jan;24(1):177-83. PubMed PMID: 8097739. 2. Adams A, Jarrott B. Thermodynamics of agonist and antagonist binding to the alpha 1-adrenoceptor studied using [125I]BE 2254. Biochem Biophys Res Commun. 1985 Apr 30;128(2):816-23. PubMed PMID: 2986627. 3. Adams A, Jarrott B. Deafferentation of the rat hippocampus does not alter the affinity or binding capacity for the alpha 1-adrenoceptor radioligand [125I]BE 2254. Neurosci Lett. 1984 Dec 21;52(3):311-6. PubMed PMID: 6097843. 4. Schlicker E, Brodde OE, G?thert M, Schaperdoth M. Increased affinity and preference of halogenated derivatives of BE 2254 for alpha 1-adrenoceptors demonstrated by functional and binding experiments. J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1238-44. PubMed PMID: 6084785.